Discovery of Kibdelomycin, A Potent New Class of Bacterial Type II Topoisomerase Inhibitor by Chemical-Genetic Profiling in Staphylococcus aureus

This Chemistry and Biology paper explains the use of a high throughput screen to discover a new antibacterial compound. Kibdelomycin was found to inhibit topoisomerases in a wide variety of gram-positive bacteria.